Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6485338

CC(C)(N)C1CCNCC1.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ARG1 P05089 1/20 0.43
ARG2 P78540 1/20 0.43
GABRP O00591 1/20 0.38
GABRD O14764 1/20 0.38
GABRA1 P14867 1/20 0.38
TSHR P16473 1/20 0.38
GABRB1 P18505 1/20 0.38
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
GABRA5 P31644 1/20 0.38
GABRA3 P34903 1/20 0.38
GABRA2 P47869 1/20 0.38
GABRB2 P47870 1/20 0.38
GABRA4 P48169 1/20 0.38
GABRE P78334 1/20 0.38
PMP22 Q01453 1/20 0.38
GABRA6 Q16445 1/20 0.38
GABRG1 Q8N1C3 1/20 0.38
GABRG3 Q99928 1/20 0.38
GABRQ Q9UN88 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1088624 0.82 ALDH1A1 (0.46) ARG1ARG2ALDH1A1TDP1MEN1
Hydrochloric Acid SCHEMBL3553549 0.80 ALDH1A1 (0.44) ARG1ARG2ALDH1A1TDP1MEN1
SCHEMBL27811491 0.79 ARG1 (0.46) ARG1ARG2GABRPGABRDGABRA1
SCHEMBL437827 0.79 ARG1 (0.46) ARG1ARG2GABRPGABRDGABRA1
Trifluoroacetic Acid SCHEMBL23120033 0.77 HRH4 (0.34) ARG1ARG2GABRPGABRDGABRA1
Trifluoroacetic Acid SCHEMBL28212086 0.76 GABRA5 (0.43) ARG1ARG2GABRPGABRDGABRA1
Trifluoroacetic Acid SCHEMBL31525039 0.76 GABRA5 (0.43) ARG1ARG2GABRPGABRDGABRA1
SCHEMBL15349787 0.75 GABRA5 (0.41) ARG1ARG2GABRPGABRDGABRA1
SCHEMBL15910211 0.74 GABRA5 (0.44) ARG1ARG2GABRPGABRDGABRA1
Trifluoroacetic Acid SCHEMBL27849942 0.74 GABRA5 (0.44) ARG1ARG2GABRPGABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6962911-B2 Pyrrolopyrimidinone derivatives, process of preparation and use SK CHEMICALS CO., LTD. (KR) 2005-11-08 US disclosed
EP-1257553-B1 PYRROLOPYRIMIDINONE DERIVATIVES, PROCESS OF PREPARATION AND USE SK CHEMICALS CO LTD (KR) 2004-05-26 EP disclosed
US-20030171361-A1 Pyrrolopyrimidinone derivatives, process of preparation and use SK CHEMICALS CO., LTD. (KR) 2003-09-11 US disclosed
EP-1257553-A1 PYRROLOPYRIMIDINONE DERIVATIVES, PROCESS OF PREPARATION AND USE SK Chemicals Co., Ltd. (KR) 2002-11-20 EP disclosed
WO-2001060825-A1 PYRROLOPYRIMIDINONE DERIVATIVES, PROCESS OF PREPARATION AND USE SK CHEMICALS CO., LTD. (KR) 2001-08-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030171361-A1 Pyrrolopyrimidinone derivatives, process of preparation and use CYP2C19, DHPS, SDHA ARG1 1682/4885ARG2 919/4885GABRP 1699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.